COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 1972: Articles 19711-19720  | Next

Betulonic acid derivatives inhibiting coronavirus replication in cell culture via the nsp15 endoribonuclease
Krasniqi, B., Stevaert, A., Van Loy, B., Nguyen, T., Thomas, J., Vandeput, J., Jochmans, D., Thiel, V., Dijkman, R., Dehaen, W., Voet, A., Naesens, L.
10.1101/2020.12.10.418996 — Posted: 2020-12-10
Molnupiravir (EIDD-2801) inhibits SARS-CoV2 replication in Syrian hamsters model
Abdelnabi, R., Foo, C. S., Kaptein, S. J. F., Zhang, X., Langendries, L., Vangeel, L., Vergote, V., Heylen, E., Dallmeier, K., Chatterjee, A., De Jonghe, S., Weynand, B., Neyts, J.
10.1101/2020.12.10.419242 — Posted: 2020-12-10
A single dose, BCG-adjuvanted SARS-CoV-2 vaccine induces Th1-polarized immunity and high-titre neutralizing antibodies in mice
Counoupas, C., Stella, A., Bhattacharyya, N., Grey, A., Patel, K., Ferguson, A., Hutchings, O., Feng, C., Palendira, U., Steain, M., Aggarwal, A., Low, J., Mackay, J., Kelleher, A., Britton, W., Turville, S., Triccas, J. A.
10.1101/2020.12.10.419044 — Posted: 2020-12-10
SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
Pyrc, K., Milewska, A., Duran, E. B., Botwina, P., Lopes, R., Arenas-Pinto, A., Badr, M., Mellor, R., Kalber, T., Fernandez-Reyes, D., Schatzlein, A. G., Uchegbu, I. F.
10.1101/2020.12.10.413609 — Posted: 2020-12-10
Social Media Insights Into US Mental Health Amid the COVID-19 Pandemic. A Longitudinal Twitter Analysis (JANUARY-APRIL 2020)
Valdez, D., ten Thij, M., Bathina, K. C., Rutter, L. A., Bollen, J.
10.1101/2020.12.01.20241943 — Posted: 2020-12-10
The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike
Guo, C., Tsai, S. J., Ai, Y., Li, M., Pekosz, A., Cox, A., Atai, N., Gould, S.
10.1101/2020.12.08.417022 — Posted: 2020-12-09
Characterization of protease activity of Nsp3 from SARS-CoV-2 and its in vitro inhibition by nanobodies
Armstrong, L., Lange, S. M., de Cesare, V., Matthews, S. P., Nirujogi, R. S., Cole, I., Hope, A., Cunningham, F., Toth, R., Mukherjee, R., Bojkova, D., Gruber, F., Gray, D., Wyatt, P. G., Cinatl, J., Dikic, I., Davies, P., Kulathu, Y.
10.1101/2020.12.09.417741 — Posted: 2020-12-09
Intranasal administration of SARS-CoV-2 neutralizing human antibody prevents infection in mice
Zhang, H., Yang, Z., Xiang, J., Cui, Z., Liu, J., Liu, C.
10.1101/2020.12.08.416677 — Posted: 2020-12-09
Intra-host variability in global SARS-CoV-2 genomes as signatures of RNA editing: implications in viral and host response outcomes
Pathak, A. K., Fatihi, S., Abbas, T., Uppili, B., Mishra, G. P., Ghosh, A., Banu, S., Bhoyar, R. C., Jain, A., Divakar, M. K., Imran, M., Faruq, M., Sowpati, D. T., Raghav, S. K., Thukral, L., Mukerji, M.
10.1101/2020.12.09.417519 — Posted: 2020-12-09
Single dose immunization with a COVID-19 DNA vaccine encoding a chimeric homodimeric protein targeting receptor binding domain (RBD) to antigen-presenting cells induces rapid, strong and long-lasting neutralizing IgG, Th1 dominated CD4+ T cells and strong CD8+ T cell responses in mice
Norheim, G., Stubsrud, E., Skullerud, L. M., Stankovic, B., Chellappa, S., Bjerkan, L., Kuczkowska, K., Muller, E., Sekelja, M., Fredriksen, A. B.
10.1101/2020.12.08.416875 — Posted: 2020-12-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).